IPEX vs SANG
Comparison between Inflection Point Acquisition Corp V - Class A (IPEX, Company) and SANGSTAT MEDICAL CORP (SANG, Company).
IPEX is from the Financial Services sector, while SANG is from the Technology sector.
IPEX vs SANG - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
IPEX vs SANG - Historical Returns
Returns include dividend reinvestment.
IPEX vs SANG - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | IPEX | SANG |
|---|---|---|
| 2026 | +1.85% | -27.51% |
| 2025 | +4.15% | -28.71% |
| 2024 | N/A | +125.95% |
| 2023 | N/A | -35.48% |
| 2022 | N/A | -74.20% |
| 2021 | N/A | +0.63% |
IPEX vs SANG Drawdown Comparison
The maximum drawdown for IPEX was -1.87%, occurring on Apr 24, 2025. Recovery took 60 trading sessions.
The maximum drawdown for SANG was -87.18%, occurring on Nov 16, 2023. This drawdown has not yet recovered.
The current IPEX drawdown is -0.29%. The current SANG drawdown is -80.80%.
| Rank | IPEX | SANG |
|---|---|---|
| #1 | -1.87% Apr 22, 2025 - Jul 18, 2025 | -87.18% Jan 3, 2022 - Nov 16, 2023 |
| #2 | -1.34% Oct 20, 2025 - Mar 26, 2026 | -17.01% Dec 9, 2021 - Jan 3, 2022 |
| #3 | -0.68% Oct 13, 2025 - Oct 20, 2025 | N/A |
| #4 | -0.50% Apr 1, 2025 - Apr 21, 2025 | N/A |
| #5 | -0.49% Jul 31, 2025 - Aug 19, 2025 | N/A |
| #6 | -0.39% Sep 29, 2025 - Oct 8, 2025 | N/A |
| #7 | -0.29% Jun 4, 2026 - Jun 12, 2026 | N/A |
| #8 | -0.24% Sep 16, 2025 - Sep 29, 2025 | N/A |
| #9 | -0.20% Jul 18, 2025 - Jul 28, 2025 | N/A |
| #10 | -0.20% Aug 19, 2025 - Sep 12, 2025 | N/A |
| #11 | -0.10% Mar 10, 2025 - Mar 18, 2025 | N/A |
| #12 | -0.10% Sep 12, 2025 - Sep 16, 2025 | N/A |
| #13 | -0.10% Mar 30, 2026 - Apr 7, 2026 | N/A |
| #14 | -0.10% Apr 7, 2026 - Apr 10, 2026 | N/A |
| #15 | -0.10% Apr 14, 2026 - Apr 27, 2026 | N/A |
Correlation
Correlation between IPEX and SANG is -0.66 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks